CAR T-Cell Therapy: Reprogramming the Immune System to Fight Cancer

We're back at a new location!

This month, BkkSci is thrilled to welcome Thanyavi Chinsuwan, an early-career researcher at the Faculty of Medicine, Chulalongkorn University. Dr. Thanyavi earned his doctorate from Shinshu University in Nagano, Japan, where his thesis focused on engineering CAR-T cells using the piggyBac transposon system and testing their efficacy against solid tumors. Currently, he's a member of the Center of Excellence in Cellular Immunotherapy at Chulalongkorn University, a site that is conducting three phase I clinical trials targeting malignancies and autoimmune diseases.

In this session, Thanyavi will delve into:

• What is immunotherapy?
• What are chimeric antigen receptors (CARs)?
• How does CAR-T cell therapy work?
• In which case does it work, and where does it not?
• What clinical trials are being done in Thailand?

Join us for an enlightening discussion on how science is harnessing the power of our own cells to fight cancer!